Innocent Gerald Asiimwe
Innocent Gerald Asiimwe
PhD student, Department of Pharmacology & Therapeutics, ISMIB, University of Liverpool
Verified email at liverpool.ac.uk
Title
Cited by
Cited by
Year
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
RK Gupta, EM Harrison, A Ho, AB Docherty, SR Knight, M van Smeden, ...
The Lancet Respiratory Medicine 9 (4), 349-359, 2021
412021
Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the …
CI Bloom, TM Drake, AB Docherty, BJ Lipworth, SL Johnston, ...
The lancet Respiratory medicine, 2021
252021
Genetic factors influencing warfarin dose in Black‐African patients: a systematic review and meta‐analysis
IG Asiimwe, EJ Zhang, R Osanlou, A Krause, C Dillon, G Suarez‐Kurtz, ...
Clinical Pharmacology & Therapeutics 107 (6), 1420-1433, 2020
182020
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre …
CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ...
The Lancet Microbe, 2021
142021
Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study
TM Drake, CJ Fairfield, R Pius, SR Knight, L Norman, M Girvan, ...
The Lancet Rheumatology, 2021
142021
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK
AB Docherty, RH Mulholland, NI Lone, CP Cheyne, D De Angelis, ...
The Lancet Respiratory Medicine, 2021
52021
Warfarin dosing algorithms: A systematic review
IG Asiimwe, EJ Zhang, R Osanlou, AL Jorgensen, M Pirmohamed
British journal of clinical pharmacology 87 (4), 1717-1729, 2021
52021
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study
TM Drake, AM Riad, CJ Fairfield, C Egan, SR Knight, R Pius, ...
The Lancet 398 (10296), 223-237, 2021
42021
Publication proportions for registered breast cancer trials: before and following the introduction of the ClinicalTrials. gov results database
IG Asiimwe, D Rumona
Research integrity and peer review 1 (1), 1-13, 2016
32016
Developing and validating a clinical warfarin dose‐initiation model for Black‐African patients in South Africa and Uganda
IG Asiimwe, C Waitt, C Sekaggya‐Wiltshire, C Hutchinson, E Okello, ...
Clinical Pharmacology & Therapeutics 109 (6), 1564-1574, 2021
12021
Cardiovascular drugs and COVID‐19 clinical outcomes: a living systematic review and meta‐analysis
IG Asiimwe, S Pushpakom, RM Turner, R Kolamunnage‐Dona, ...
British Journal of Clinical Pharmacology, 2021
12021
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease: An International Multicenter Study.
J Hutchinson, ISARIC4C Investigators
2020
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score
MG Semple
The system can't perform the operation now. Try again later.
Articles 1–13